Taizo Mori

507 total citations
25 papers, 284 citations indexed

About

Taizo Mori is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Taizo Mori has authored 25 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Immunology and 6 papers in Hepatology. Recurrent topics in Taizo Mori's work include Liver Disease Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Diet, Metabolism, and Disease (5 papers). Taizo Mori is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Diet, Metabolism, and Disease (5 papers). Taizo Mori collaborates with scholars based in Japan, United States and Australia. Taizo Mori's co-authors include Sachiyo Yoshio, Tatsuya Kanto, Hironari Kawai, Satoshi Τακακι, Taiji Yamazoe, Yosuke Osawa, Masanori Iseki, Yuzuru Sakamoto, Yukiko Iwasaki and Kiyoshi Takatsu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Taizo Mori

25 papers receiving 280 citations

Peers

Taizo Mori
Jin-Seok Byun South Korea
Zohreh Jadali Iran
Yuya Hagihara Japan
Rosina Maria Critelli Italy
S Calabrò Australia
Anja Schulze-Krebs Germany
Takuya Nagano Japan
O. Hajoui Canada
Xingang Zhou China
Jarren R. Oates United States
Jin-Seok Byun South Korea
Taizo Mori
Citations per year, relative to Taizo Mori Taizo Mori (= 1×) peers Jin-Seok Byun

Countries citing papers authored by Taizo Mori

Since Specialization
Citations

This map shows the geographic impact of Taizo Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taizo Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taizo Mori more than expected).

Fields of papers citing papers by Taizo Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taizo Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taizo Mori. The network helps show where Taizo Mori may publish in the future.

Co-authorship network of co-authors of Taizo Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Taizo Mori. A scholar is included among the top collaborators of Taizo Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taizo Mori. Taizo Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshio, Sachiyo, Taiji Yamazoe, Taizo Mori, et al.. (2024). Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma. Frontiers in Immunology. 15. 1389411–1389411. 2 indexed citations
2.
Matsumura, Kazunori, Taizo Mori, Taeko Dohi, Yuki I. Kawamura, & Satoshi Τακακι. (2024). Composition of fatty acids in a high‐fat diet affects adipose tissue inflammation by inducing calreticulin on adipocytes and activating group 1 innate lymphoid cells. European Journal of Immunology. 54(4). e2350800–e2350800. 1 indexed citations
3.
Kakazu, Eiji, Hiroko Matsubara, Keisuke Kakisaka, et al.. (2024). Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism. Amino Acids. 57(1). 3–3. 4 indexed citations
4.
Kakazu, Eiji, Hiroko Matsubara, Keisuke Kakisaka, et al.. (2024). Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.. Journal of Gastroenterology. 59(6). 483–493. 6 indexed citations
5.
Osawa, Yosuke, Hironari Kawai, Keigo Nakashima, et al.. (2024). Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis. PLoS ONE. 19(5). e0303296–e0303296. 5 indexed citations
6.
Mori, Taizo, Sachiyo Yoshio, Eiji Kakazu, & Tatsuya Kanto. (2024). Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.. PubMed. 12. goae089–goae089. 6 indexed citations
7.
Kakazu, Eiji, Hisayuki Katsuyama, Mariko Hakoshima, et al.. (2023). Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB‐4 index in metabolic‐associated fatty liver disease. Hepatology Research. 53(7). 618–628. 8 indexed citations
8.
Mori, Taizo, Sachiyo Yoshio, Yuichi Yoshida, et al.. (2023). Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse model. Hepatology Communications. 7(10). 5 indexed citations
9.
Ito, Takanori, Sachiyo Yoshio, Takafumi Yamamoto, et al.. (2023). Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma. Journal of Gastroenterology. 58(6). 565–574. 6 indexed citations
10.
Takeuchi, Fumihiko, Masato Isono, Mia Yang Ang, et al.. (2023). Gene-regulation modules in nonalcoholic fatty liver disease revealed by single-nucleus ATAC-seq. Life Science Alliance. 6(10). e202301988–e202301988. 1 indexed citations
11.
Mori, Taizo, Sachiyo Yoshio, Yuzuru Sakamoto, et al.. (2023). Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro. Liver International. 43(6). 1213–1224. 5 indexed citations
12.
Osawa, Yosuke, Sachiyo Yoshio, Yoshihiko Aoki, et al.. (2021). Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterology. 21(1). 55–55. 14 indexed citations
13.
Yoshio, Sachiyo, Tomonari Shimagaki, Ryuki Hashida, et al.. (2021). Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma. Hepatology Research. 51(7). 803–812. 23 indexed citations
14.
Osawa, Yosuke, Hironari Kawai, Tomoyuki Tsunoda, et al.. (2021). Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy. Hepatology Communications. 5(8). 1437–1447. 28 indexed citations
15.
Yoshio, Sachiyo, Taiji Yamazoe, Taizo Mori, et al.. (2021). Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma. Cells. 10(6). 1495–1495. 14 indexed citations
16.
Yamazoe, Taiji, Taizo Mori, Sachiyo Yoshio, & Tatsuya Kanto. (2020). Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics. Global Health & Medicine. 2(5). 273–281. 6 indexed citations
17.
Shimagaki, Tomonari, Sachiyo Yoshio, Hironari Kawai, et al.. (2019). Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports. 9(1). 15788–15788. 22 indexed citations
18.
19.
Yoshio, Sachiyo, Yohei Mano, Hiroyoshi Doi, et al.. (2018). Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients. JCI Insight. 3(20). 30 indexed citations
20.
Mori, Taizo, et al.. (2018). Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs. Cell Reports. 24(7). 1830–1841. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Seok Byun Breakdown of academic impact, for papers by Zohreh Jadali Breakdown of academic impact, for papers by Yuya Hagihara Breakdown of academic impact, for papers by Rosina Maria Critelli Breakdown of academic impact, for papers by S Calabrò Breakdown of academic impact, for papers by Anja Schulze-Krebs Breakdown of academic impact, for papers by Takuya Nagano Breakdown of academic impact, for papers by O. Hajoui Breakdown of academic impact, for papers by Xingang Zhou Breakdown of academic impact, for papers by Jarren R. Oates
Rankless by CCL
2026